About: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: 19 November 1992)

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 1992 (ast) vědecký článek publikovaný v roce 1992 (cs) 1992 թվականի նոյեմբերին հրատարակված գիտական հոդված (hy) 1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած (hyw) наукова стаття, опублікована в листопаді 1992 (uk) article scientifique publié en 1992 (fr) im November 1992 veröffentlichter wissenschaftlicher Artikel (de) wetenschappelijk artikel (gepubliceerd op 1992/11/19) (nl) vedecký článok (publikovaný 1992/11/19) (sk) scientific article (publication date: 19 November 1992) (en) مقالة علمية (نشرت في 19-11-1992) (ar)
publication date	wds:Q28188441-506BFA85-E314-4FE5-9F43-DC398F62E777
publication date	1992-11-19 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28188441-5E7E8538-39AE-42EB-80D7-78BB2662F6C8
language of work or name	English
author name string	wds:Q28188441-31E6CCAF-9B82-4F42-BEA2-DA66D97CC44A wds:Q28188441-37AAD3CE-220C-46B8-BDD0-18943644A46C wds:Q28188441-47E90190-FF88-4B1B-AED0-1AFA7C7610CA wds:Q28188441-9B376F3A-34C6-4BFC-B50B-C045E5DD40C6 wds:Q28188441-A388D6E4-D2C6-4649-A2F5-663ECC6850AF wds:Q28188441-BA128321-84DC-4445-83AB-6BF362F5BDC8 wds:Q28188441-BE15BDF9-C2E9-41AB-AF3E-5D795FB8CEF5 wds:Q28188441-D67524E8-EA51-4A65-B0FC-930391E55DA8 wds:Q28188441-DF12AF07-808B-4F02-974D-7E94E1736C11
OpenCitations bibliographic resource ID	wds:Q28188441-00CE833D-FA14-4038-A63E-C53C8FB1BD92
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/1456312
author name string	J R Anderson M R Green B A Peterson M R Cooper K J Propert G P Canellos A Gottlieb E S Henderson N Nissen
OpenCitations bibliographic resource ID	1456312
rdfs:label	Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (en) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (nl) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (ast)
skos:prefLabel	Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (en) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (nl) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (ast)
name	Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (en) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (nl) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (ast)
title	wds:Q28188441-4E7CC6B8-4A0B-48A8-81F4-254F94A855CC
title	Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD (en)
page(s)	wds:Q28188441-C644A832-B7CF-457E-9336-34670CC74032
page(s)	1478-84
instance of	wds:Q28188441-C535EC45-4A82-441A-84A0-9830038AEB4C
instance of	scholarly article
main subject	wds:Q28188441-FBA6EDEA-0818-4447-9C3B-3460A61C006F
main subject	chemotherapy
PubMed ID	wds:Q28188441-51A5286B-5353-4FE4-A95C-E7826B810CAD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1383821
PubMed ID	1383821
published in	wds:Q28188441-7C239D52-D4D7-495A-AEB9-241755BBF99D
published in	The New England Journal of Medicine
issue	wds:Q28188441-10CD2820-A389-4420-91D6-23C467165F31
volume	wds:Q28188441-37ABDBAB-9A99-4757-8895-913C9915325D
issue	21
volume	327
DOI	wds:Q28188441-AD67817F-F914-45E8-B824-71C96B957C4C
DOI	http://dx.doi.org/10.1056/NEJM199211193272102
DOI	10.1056/NEJM199211193272102
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28188441
is cites work of	Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006. Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Two-way referral bias: evidence from a clinical audit of lymphoma in a teaching hospital 14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy. Recent developments in the management of haemophagocytic lymphohistiocytosis Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments? Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity Toxicity of chemotherapy Tumor-associated macrophages and survival in classic Hodgkin's lymphoma Radiation therapy during pregnancy MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496) Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305). Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Long-term survival after treatment for Hodgkin's disease (1973-2002): improved survival with successive 10-year cohorts EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects Gene expression profiling defines molecular subtypes of classical Hodgkin's disease. The emergence of resistance to targeted cancer therapeutics Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET State of the art in the treatment of Hodgkin lymphoma Cardiac morbidity following modern treatment for Hodgkin lymphoma: Supra-additive cardiotoxicity of doxorubicin and radiation therapy Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software